SC 13D/A | 2017-02-23 | GAMCO INVESTORS, INC. ET AL | VASCULAR SOLUTIONS INC | - | 0.0% | EDGAR |
SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | VASCULAR SOLUTIONS INC | 669,976 | 3.8% | EDGAR |
SC 13D | 2017-01-31 | GAMCO INVESTORS, INC. ET AL | VASCULAR SOLUTIONS INC | 598,717 | 3.4% | EDGAR |
SC 13G/A | 2017-01-17 | BlackRock Inc. | VASCULAR SOLUTIONS INC | 2,011,293 | 11.5% | EDGAR |
SC 13G/A | 2016-08-09 | BlackRock Inc. | VASCULAR SOLUTIONS INC | 1,761,431 | 10.1% | EDGAR |
SC 13G/A | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | VASCULAR SOLUTIONS INC | 1,118,828 | 6.4% | EDGAR |
SC 13G/A | 2016-02-10 | RBC Global Asset Management (U.S.) | VASCULAR SOLUTIONS INC | 735,691 | 4.2% | EDGAR |
SC 13G | 2016-01-28 | BlackRock Inc. | VASCULAR SOLUTIONS INC | 1,572,240 | 9.1% | EDGAR |
SC 13G/A | 2015-02-12 | WELLINGTON MANAGEMENT GROUP LLP | VASCULAR SOLUTIONS INC | 1,505,765 | 8.8% | EDGAR |
SC 13G/A | 2015-02-04 | RBC Global Asset Management (U.S.) | VASCULAR SOLUTIONS INC | 906,337 | 5.3% | EDGAR |
SC 13G | 2014-02-14 | WELLINGTON MANAGEMENT CO LLP | VASCULAR SOLUTIONS INC | 903,872 | 5.4% | EDGAR |
SC 13G | 2014-02-10 | RBC Global Asset Management (U.S.) | VASCULAR SOLUTIONS INC | 915,333 | 5.4% | EDGAR |
SC 13G/A | 2012-12-31 | STEPHENS WARREN A | VASCULAR SOLUTIONS INC | 597,162 | 3.7% | EDGAR |
SC 13G/A | 2012-02-13 | STEPHENS WARREN A | VASCULAR SOLUTIONS INC | 1,191,362 | 7.2% | EDGAR |
SC 13G/A | 2011-02-14 | STEPHENS WARREN A | VASCULAR SOLUTIONS INC | 1,191,362 | 7.1% | EDGAR |
SC 13D/A | 2010-12-28 | SF HOLDING CORP | VASCULAR SOLUTIONS INC | - | 0.0% | EDGAR |
SC 13G | 2010-11-29 | STEPHENS WARREN A | VASCULAR SOLUTIONS INC | 1,194,312 | 7.1% | EDGAR |
SC 13D/A | 2010-09-03 | SF HOLDING CORP | VASCULAR SOLUTIONS INC | 2,138,819 | 0.0% | EDGAR |
SC 13G/A | 2009-02-12 | Kairos Partners III Limited Partnership | VASCULAR SOLUTIONS INC | - | - | EDGAR |
SC 13G/A | 2008-02-12 | Kairos Partners III Limited Partnership | VASCULAR SOLUTIONS INC | - | - | EDGAR |